Flagship Harbor Advisors, LLC Reata Pharmaceuticals Inc Transaction History

Flagship Harbor Advisors, LLC

  • $1.74 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 08, 2021
SELL
$102.03 - $184.62 $9,590 - $17,354
-94 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$74.57 - $217.92 $1,789 - $5,230
24 Added 34.29%
94 $19,000
Q2 2019

Jul 22, 2019
BUY
$77.72 - $94.35 $5,440 - $6,604
70 New
70 $6,000

Others Institutions Holding RETA

# of Institutions
5
Shares Held
62.7K
Call Options Held
0
Put Options Held
0
View Full List

About REATA PHARMACEUTICALS INC

RETA Quotes by TradingView
  • Ticker RETA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,583,200
  • Description
  • Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...
More about RETA
Track This Portfolio

Track Flagship Harbor Advisors, LLC Portfolio

Follow Flagship Harbor Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Flagship Harbor Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Flagship Harbor Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email